Update on Management of Type 2 Diabetes for Cardiologists

Mohammed Qureshi; Emily Gammoh; Jawairia Shakil; Richard Robbins

doi:10.14797/mdcj-14-4-273

Update on Management of Type 2 Diabetes for Cardiologists

Mohammed Qureshi, Emily Gammoh, Jawairia Shakil, Richard Robbins

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Abstract

The management of type 2 diabetes mellitus has evolved over the last several years as new antidiabetic agents continue to arrive and change the goals of diabetes care. In 2008, the U.S. Food and Drug Administration mandated that all new antidiabetic agents must demonstrate cardiovascular (CV) safety, which has led to a series of CV outcome trials. In this article, we review the key findings from these CV outcome trials and their impact on diabetes care guidelines.

Original language	English (US)
Pages (from-to)	273-280
Number of pages	8
Journal	Methodist DeBakey cardiovascular journal
Volume	14
Issue number	4
DOIs	https://doi.org/10.14797/mdcj-14-4-273
State	Published - Oct 1 2018

Keywords

cardiovascular outcome trials
cardiovascular safety
diabetes management
major adverse cardiac events
type 2 diabetes mellitus

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.14797/mdcj-14-4-273

Cite this

@article{e3bc8299f6e14cb4be9c2055ad98c1bc,

title = "Update on Management of Type 2 Diabetes for Cardiologists",

abstract = "The management of type 2 diabetes mellitus has evolved over the last several years as new antidiabetic agents continue to arrive and change the goals of diabetes care. In 2008, the U.S. Food and Drug Administration mandated that all new antidiabetic agents must demonstrate cardiovascular (CV) safety, which has led to a series of CV outcome trials. In this article, we review the key findings from these CV outcome trials and their impact on diabetes care guidelines.",

keywords = "cardiovascular outcome trials, cardiovascular safety, diabetes management, major adverse cardiac events, type 2 diabetes mellitus",

author = "Mohammed Qureshi and Emily Gammoh and Jawairia Shakil and Richard Robbins",

note = "Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine",

year = "2018",

month = oct,

day = "1",

doi = "10.14797/mdcj-14-4-273",

language = "English (US)",

volume = "14",

pages = "273--280",

journal = "Methodist DeBakey cardiovascular journal",

issn = "1947-6094",

publisher = "Methodist DeBakey Heart & Vascular Center",

number = "4",

}

TY - JOUR

T1 - Update on Management of Type 2 Diabetes for Cardiologists

AU - Qureshi, Mohammed

AU - Gammoh, Emily

AU - Shakil, Jawairia

AU - Robbins, Richard

N1 - Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine

PY - 2018/10/1

Y1 - 2018/10/1

N2 - The management of type 2 diabetes mellitus has evolved over the last several years as new antidiabetic agents continue to arrive and change the goals of diabetes care. In 2008, the U.S. Food and Drug Administration mandated that all new antidiabetic agents must demonstrate cardiovascular (CV) safety, which has led to a series of CV outcome trials. In this article, we review the key findings from these CV outcome trials and their impact on diabetes care guidelines.

AB - The management of type 2 diabetes mellitus has evolved over the last several years as new antidiabetic agents continue to arrive and change the goals of diabetes care. In 2008, the U.S. Food and Drug Administration mandated that all new antidiabetic agents must demonstrate cardiovascular (CV) safety, which has led to a series of CV outcome trials. In this article, we review the key findings from these CV outcome trials and their impact on diabetes care guidelines.

KW - cardiovascular outcome trials

KW - cardiovascular safety

KW - diabetes management

KW - major adverse cardiac events

KW - type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=85061969396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061969396&partnerID=8YFLogxK

U2 - 10.14797/mdcj-14-4-273

DO - 10.14797/mdcj-14-4-273

M3 - Review article

C2 - 30788013

AN - SCOPUS:85061969396

SN - 1947-6094

VL - 14

SP - 273

EP - 280

JO - Methodist DeBakey cardiovascular journal

JF - Methodist DeBakey cardiovascular journal

IS - 4

ER -

Update on Management of Type 2 Diabetes for Cardiologists

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this